Caliway Biopharmaceuticals Co., Ltd. (TPE: 6919)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
587.00
+1.00 (0.17%)
At close: Jan 3, 2025
206.93%
Market Cap 92.22B
Revenue (ttm) 49.98M
Net Income (ttm) -651.00M
Shares Out 153.44M
EPS (ttm) -4.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 623,993
Open 593.00
Previous Close 586.00
Day's Range 582.00 - 602.00
52-Week Range 240.50 - 800.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 5, 2025

About Caliway Biopharmaceuticals

Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6919
Full Company Profile

Financial Performance

In 2023, Caliway Biopharmaceuticals's revenue was 38.93 million, an increase of 203.68% compared to the previous year's 12.82 million. Losses were -488.46 million, 70.7% more than in 2022.

Financial Statements

News

There is no news available yet.